Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells
Gianmarco Abbadessa, Elisabetta Maida, Giuseppina Miele, Luigi Lavorgna, Girolama Alessandra Marfia, Paola Valentino, Antonio Martino, Paola Cavalla, Simona Bonavita
Topics & Concepts
OcrelizumabMedicineMultiple sclerosisInternal medicineCD8LymphocyteGastroenterologyPopulationImmunologyImmune systemRituximabEnvironmental healthLymphomaMultiple Sclerosis Research StudiesImmunotherapy and Immune ResponsesPeripheral Neuropathies and Disorders